Want to see JP:7600 full AI Analyst Report?
7600 Stock Chart & Stats
¥487.00
-¥2.00(-0.33%)
At close: 4:00 PM EST
¥487.00
-¥2.00(-0.33%)
Day’s Range― - ―
52-Week Range¥445.00 - ¥946.00
Previous CloseN/A
Volume41.50K
Average Volume (3M)89.74K
Market Cap
¥22.86B
Enterprise Value¥26.35B
Total Cash (Recent Filing)¥3.11B
Total Debt (Recent Filing)¥5.87B
Price to Earnings (P/E)87.6
Beta0.63
Next Earnings
Jul 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.12%
Share Statistics
EPS (TTM)9.98
Shares Outstanding26,475,880
10 Day Avg. Volume96,020
30 Day Avg. Volume89,743
Financial Highlights & Ratios
PEG Ratio-0.34
Price to Book (P/B)0.56
Price to Sales (P/S)0.59
P/FCF Ratio-8.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)18.2
Revenue Forecast (FY)¥25.30B
Bulls Say, Bears Say
Bulls Say
Solid Balance SheetA large equity base and moderate debt provide durable financial flexibility. That capacity helps fund capex, absorb short-term shocks, and pursue restructuring or selective M&A without immediate reliance on volatile capital markets, supporting a multi-quarter recovery plan.
Return To Profitability And Healthy Gross MarginReturning to profit while retaining healthy gross margins shows the core product economics remain intact. This implies pricing power or cost-of-goods stability, enabling operating leverage to restore margins over time if revenue stabilizes and SG&A is controlled.
Prior Revenue And Free-cash-flow StrengthA track record of strong top-line growth and positive FCF in prior years indicates the business model can scale profitably. This historical cash generation capacity increases the likelihood that temporary headwinds are recoverable with disciplined execution and demand normalization.
Bears Say
Severe Cash-flow DeteriorationDeeply negative FCF and collapsing operating cash flow materially weaken internal funding for capex, R&D, and working capital. Persistent cash deficits force external financing or asset sales, limit strategic options, and undermine earnings quality until cash conversion meaningfully recovers.
Compressed Profitability And Declining RevenueA sharp margin compression and a year of negative revenue growth reduce the firm's ability to generate returns on invested capital. Sustained low margins increase vulnerability to competition and cost shocks, and recovery requires either revenue reacceleration or structural cost cuts.
Rising Leverage And Weak Returns On EquityAn increase in leverage combined with very low ROE means the balance sheet is less effective at compounding shareholder value. Higher leverage raises fixed interest burdens, constraining flexibility while weak profitability makes deleveraging difficult without sustained operational improvement.
Japan Medical Dynamic Marketing, Inc. News
7600 FAQ
What was Japan Medical Dynamic Marketing, Inc.’s price range in the past 12 months?
Japan Medical Dynamic Marketing, Inc. lowest stock price was ¥445.00 and its highest was ¥946.00 in the past 12 months.
What is Japan Medical Dynamic Marketing, Inc.’s market cap?
Japan Medical Dynamic Marketing, Inc.’s market cap is ¥22.86B.
When is Japan Medical Dynamic Marketing, Inc.’s upcoming earnings report date?
Japan Medical Dynamic Marketing, Inc.’s upcoming earnings report date is Jul 24, 2026 which is in 21 days.
How were Japan Medical Dynamic Marketing, Inc.’s earnings last quarter?
Japan Medical Dynamic Marketing, Inc. released its earnings results on Apr 30, 2026. The company reported -¥0.91 earnings per share for the quarter, missing the consensus estimate of N/A by -¥0.91.
Is Japan Medical Dynamic Marketing, Inc. overvalued?
According to Wall Street analysts Japan Medical Dynamic Marketing, Inc.’s price is currently Overvalued.
Does Japan Medical Dynamic Marketing, Inc. pay dividends?
Japan Medical Dynamic Marketing, Inc. pays a Annually dividend of ¥17 which represents an annual dividend yield of 3.12%. See more information on Japan Medical Dynamic Marketing, Inc. dividends here
What is Japan Medical Dynamic Marketing, Inc.’s EPS estimate?
Japan Medical Dynamic Marketing, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Japan Medical Dynamic Marketing, Inc. have?
Japan Medical Dynamic Marketing, Inc. has 26,475,880 shares outstanding.
What happened to Japan Medical Dynamic Marketing, Inc.’s price movement after its last earnings report?
Japan Medical Dynamic Marketing, Inc. reported an EPS of -¥0.91 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 9.344%.
Which hedge fund is a major shareholder of Japan Medical Dynamic Marketing, Inc.?
Currently, no hedge funds are holding shares in JP:7600
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Japan Medical Dynamic Marketing, Inc.
Japan Medical Dynamic Marketing, Inc. (JMDM) engages in the development, production, importation, and distribution of medical instruments throughout Japan and the United States. Its product portfolio features a variety of trauma devices, including surgical nails, screws, and plates, engineered for implantation at fracture sites. JMDM also offers joint prostheses, which are designed to replace compromised natural joints and restore functions impaired by disease or injury. Additionally, the company supplies spinal stabilization systems for operations addressing spinal instability, as well as synthetic bone grafts used in the treatment of bone fractures, tumors, and other structural deficiencies. These specialized medical solutions are provided to healthcare professionals and hospitals. Founded in 1973, the firm's headquarters are located in Tokyo, Japan.
Technical Analysis
CYBERDYNE
―
PHC Holdings Corp.
―
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Options Prices
Currently, No data available
---